Clinical trial
The Effect of Vitamin D Supplementation on Chromium Serum Levels and Insulin Resistance Among Overweight Jordanian Women With Polycystic Ovary Syndrome in Irbid
NCT02328404 is registered in ClinicalTrials.gov with Hayat Pharmaceutical Co. PLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Vitamin D Supplementation on Chromium Serum Levels and Insulin Resistance Among Overweight Jordanian Women With Polycystic Ovary Syndrome in Irbid
- Lead sponsor
- Hayat Pharmaceutical Co. PLC
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- February 28, 2014
- Completion date
- December 31, 2014
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hypovitaminosis d, polycystic ovary syndrome